In summary, CA-NPs exhibit significant hepatoprotective effects in the D-Gal and radiation-induced acute hepatitis rat model by inhibiting the MyD88/TLR4 pathway, providing experimental evidence for their clinical application in treating acute hepatitis. This evidence concerns the gene MYD88 and Acute hepatitis.